ST. JOHNS, Fla.–(BUSINESS WIRE)–Residents of Florida and the Southeast should be alert for the potential impacts…
Categoría: Business Wire
Category Added in a WPeMatico Campaign
RIBOMIC Announces Completion of Patient Enrollment in Early Phase II Study of umedaptanib pegol for Achondroplasia and Initiation of Dosing in Cohort 2 of Early Phase II Clinical Study
TOKYO–(BUSINESS WIRE)–RIBOMIC Inc. (TOKYO:4591), a clinical-stage pharmaceutical company specializing in aptamer therapeutics, today announced that 13…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Five Below, Inc. (FIVE) Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces…
Rosen Law Firm Encourages Stellantis N.V. Investors to Inquire About Securities Class Action Investigation – STLA
NEW YORK–(BUSINESS WIRE)–Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of…
A Rent Cap is NOT Rent Control, says California’s Prop. 33 Campaign
Advocates say flawed 2019 ‘California Tenant Protection Act’ is really a Landlord Protection Act LOS ANGELES–(BUSINESS…
Riot Platforms, Inc. Reports Beneficial Ownership of 16.9% in Bitfarms Ltd.
CASTLE ROCK, Colo.–(BUSINESS WIRE)–Riot Platforms, Inc. (“Riot”) issues this press release pursuant to Part 3 of…
SMART Global Holdings Announces Pricing of Upsized Private Offering of $175.0 Million Convertible Notes
MILPITAS, Calif.–(BUSINESS WIRE)–$SGH #ConvertibleNotes—SMART Global Holdings, Inc. (“SGH,” “we” or the “Company”) (Nasdaq: SGH) today announced…
CYH Investors Have Opportunity to Join Community Health Systems, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is…
Cencosud S.A. Increases Profit by 75.1% in Second Quarter
Revenues rose by 9.9% year-over-year, totaling CLP 3,962,806 million (USD 4,240 million). This growth reflects a…
Adaptimmune Receives U.S. FDA Accelerated Approval of TECELRA® (afamitresgene autoleucel), the First Approved Engineered Cell Therapy for a Solid Tumor
Approved for advanced MAGE-A4+synovial sarcoma in adults with certain HLA types who have received prior chemotherapy…